[go: up one dir, main page]

FI20030652A0 - Parannettu immunomääritys - Google Patents

Parannettu immunomääritys

Info

Publication number
FI20030652A0
FI20030652A0 FI20030652A FI20030652A FI20030652A0 FI 20030652 A0 FI20030652 A0 FI 20030652A0 FI 20030652 A FI20030652 A FI 20030652A FI 20030652 A FI20030652 A FI 20030652A FI 20030652 A0 FI20030652 A0 FI 20030652A0
Authority
FI
Finland
Prior art keywords
ctni
terminal part
directed
antibody
improved immune
Prior art date
Application number
FI20030652A
Other languages
English (en)
Swedish (sv)
Inventor
Susann Eriksson
Kim Pettersson
Original Assignee
Susann Eriksson
Kim Pettersson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Susann Eriksson, Kim Pettersson filed Critical Susann Eriksson
Priority to FI20030652A priority Critical patent/FI20030652A0/fi
Publication of FI20030652A0 publication Critical patent/FI20030652A0/fi
Priority to ES04076042T priority patent/ES2264079T3/es
Priority to EP04076042A priority patent/EP1473567B1/en
Priority to DE602004001533T priority patent/DE602004001533T2/de
Priority to AT04076042T priority patent/ATE333649T1/de
Priority to US10/819,213 priority patent/US7348157B2/en
Priority to US11/979,977 priority patent/US7638292B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/973—Simultaneous determination of more than one analyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
FI20030652A 2003-04-30 2003-04-30 Parannettu immunomääritys FI20030652A0 (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20030652A FI20030652A0 (fi) 2003-04-30 2003-04-30 Parannettu immunomääritys
ES04076042T ES2264079T3 (es) 2003-04-30 2004-04-01 Inmunoensayo de troponina cardiaca i.
EP04076042A EP1473567B1 (en) 2003-04-30 2004-04-01 Immunoassay for cardiac troponin I
DE602004001533T DE602004001533T2 (de) 2003-04-30 2004-04-01 Immunoassay von kardialem Troponin I
AT04076042T ATE333649T1 (de) 2003-04-30 2004-04-01 Immunotestverfahren für herz-troponin i
US10/819,213 US7348157B2 (en) 2003-04-30 2004-04-07 Immunoassay
US11/979,977 US7638292B2 (en) 2003-04-30 2007-11-13 Immunoassay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20030652A FI20030652A0 (fi) 2003-04-30 2003-04-30 Parannettu immunomääritys

Publications (1)

Publication Number Publication Date
FI20030652A0 true FI20030652A0 (fi) 2003-04-30

Family

ID=8566047

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20030652A FI20030652A0 (fi) 2003-04-30 2003-04-30 Parannettu immunomääritys

Country Status (6)

Country Link
US (2) US7348157B2 (fi)
EP (1) EP1473567B1 (fi)
AT (1) ATE333649T1 (fi)
DE (1) DE602004001533T2 (fi)
ES (1) ES2264079T3 (fi)
FI (1) FI20030652A0 (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018577A1 (en) 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
CN101438146B (zh) * 2006-04-04 2014-12-10 神谷来克斯公司 高灵敏标志物分析和分子检测的方法和组合物
AU2014200749B2 (en) * 2006-04-04 2016-04-14 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
CN103353531B (zh) * 2006-04-04 2019-03-08 神谷来克斯公司 用于肌钙蛋白分析的高灵敏系统和方法
CA2667119C (en) * 2006-10-18 2016-04-12 Axela Inc. Measuring multiple analytes over a broad range of concentrations using optical diffraction
MX2009004460A (es) 2006-10-26 2009-07-09 Abbott Lab Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
US7776605B2 (en) 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
US8338189B2 (en) * 2008-03-05 2012-12-25 Axela Inc. Detection of biomarkers and biomarker complexes
JP5678045B2 (ja) 2009-06-08 2015-02-25 シンギュレックス・インコーポレイテッド 高感度バイオマーカーパネル
CN102549429B (zh) * 2009-09-14 2015-08-19 皇家飞利浦电子股份有限公司 使用大颗粒标记的高灵敏性免疫测定
EP2480887B1 (en) * 2009-09-23 2015-12-16 Koninklijke Philips N.V. Binding assay with multiple magnetically labelled tracer binding agents
US20110136141A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
JP2013525820A (ja) 2010-05-06 2013-06-20 シングレクス、インコーポレイテッド 関節リウマチの発症に関するリスクを診断し、病期分類し、予測し、治療レスポンダーを同定するための方法
US20110306148A1 (en) 2010-06-14 2011-12-15 Siemens Healthcare Diagnostics Inc. Composition for use as an assay reagent
SG10201913370PA (en) 2012-07-03 2020-03-30 Univ Washington Antibodies to tau
CN103940986B (zh) * 2014-03-24 2015-10-21 安徽省煦棠医疗科技有限公司 肌钙蛋白i特定位点抗体制备及其检测试剂盒
TWI734975B (zh) 2014-06-27 2021-08-01 美商Ｃ２Ｎ醫療診斷有限責任公司 人類化抗-tau抗體
AU2014407088B2 (en) 2014-09-26 2021-09-23 Somalogic Operating Co., Inc. Cardiovascular risk event prediction and uses thereof
JP6651794B2 (ja) * 2015-11-05 2020-02-19 富士レビオ株式会社 心筋トロポニンｉ測定試薬及び方法
CN111018973B (zh) * 2018-10-10 2022-04-01 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的重组抗体
CN111018981B (zh) * 2018-10-10 2021-12-03 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的抗体及其应用
CN111018974B (zh) * 2018-10-10 2022-04-01 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的重组抗体
CN111018978B (zh) * 2018-10-10 2022-11-04 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的抗体及其应用
CN111018982B (zh) * 2018-10-10 2021-12-03 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的抗体及其应用
CN111018977B (zh) * 2018-10-10 2022-04-01 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的重组抗体
CN111018975B (zh) * 2018-10-10 2022-04-01 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的重组抗体
CN111018980B (zh) * 2018-10-10 2021-12-03 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的抗体及其应用
CN111018979B (zh) * 2018-10-10 2021-12-03 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的抗体及其应用
CN110836973A (zh) * 2019-09-09 2020-02-25 浙江博实生物科技有限公司 检测肌钙蛋白及复合物的双标记试剂盒及制备与检测方法
CN111308085B (zh) * 2019-12-30 2021-02-23 菲鹏生物股份有限公司 一种超敏心肌肌钙蛋白i检测方法和试剂盒
CN114384249A (zh) * 2020-10-16 2022-04-22 广东菲鹏生物有限公司 一种心肌肌钙蛋白i检测方法和试剂盒
CN114034869A (zh) * 2020-10-16 2022-02-11 广东菲鹏生物有限公司 一种心肌肌钙蛋白i检测方法和试剂盒
US20220145363A1 (en) * 2020-11-09 2022-05-12 Meso Scale Technologies, Llc. Methods and kits for detecting tau
WO2025035370A1 (zh) * 2023-08-14 2025-02-20 深圳迈瑞生物医疗电子股份有限公司 检测总cTnITC的组合物、试剂盒和方法、及其应用
WO2025229075A1 (en) * 2024-05-03 2025-11-06 Sphingotec Gmbh A method for the specific determination of proenkephalin fragment 119-159

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027156A1 (en) * 1993-05-17 1994-11-24 Fortron Bioscience, Inc. Assay for cardiac troponin i
DE19524572A1 (de) * 1995-07-06 1997-01-09 Bayer Ag Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Immunoassays, bestehend aus den Analyten oder Teilsequenzen davon, die an inerten Trägermoleküle konjugiert sind
WO1997049994A1 (en) 1996-06-25 1997-12-31 Oy Aboatech Ab Method and kit for the diagnosis of troponin i
WO1998029726A2 (en) * 1996-12-27 1998-07-09 Coulter International Corp. Method of detecting and determining the concentration of total troponin i in a biological sample
FR2779526A1 (fr) * 1998-06-09 1999-12-10 Pasteur Sanofi Diagnostics Nouveau procede de dosage de la troponine i cardiaque
US20040018577A1 (en) * 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay

Also Published As

Publication number Publication date
US20040219604A1 (en) 2004-11-04
US7638292B2 (en) 2009-12-29
US20080153109A1 (en) 2008-06-26
DE602004001533T2 (de) 2007-02-15
DE602004001533D1 (de) 2006-08-31
US7348157B2 (en) 2008-03-25
EP1473567B1 (en) 2006-07-19
ATE333649T1 (de) 2006-08-15
EP1473567A1 (en) 2004-11-03
ES2264079T3 (es) 2006-12-16

Similar Documents

Publication Publication Date Title
FI20030652A0 (fi) Parannettu immunomääritys
EA200500643A1 (ru) Способ неконкурентного иммуноанализа для определения малых аналитов
ATE487946T1 (de) Analytischer sandwichtest zur bestimmung von nt- probnp
DK1625163T3 (da) Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43
ES2129421T3 (es) Anticuerpos monoclonales que reconocen el extremo c de hbnp.
NO20001273L (no) Immunanalyse for BNP
WO1999022242A3 (en) Measurement of glycated hemoglobin
ATE459885T1 (de) Verfahren zur besserung der wiederfindung troponin i und t
DE69132864D1 (de) Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap
DE69232801D1 (de) Abtrennungsverfahren
DK0460190T3 (da) Fremgangsmåde til påvisning af maligne sygdomme
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
EP1304336A3 (de) Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführte Nachweisverfahren
KR870007426A (ko) 모노클로날항체및 이를 이용한 글루콕실화 단백질의 측정방법과 측정기기
DE59712595D1 (de) Homogene Nachweisverfahren zur Bestimmung von Subpopulationen eines Analyten
WO2004084841A3 (en) Novel anti-feline albumin antibodies and methods of detecting early renal disease
ATE112392T1 (de) Agglutinationskomplex zum nachweis von blutgruppen.
WO1998029726A3 (en) Method of detecting and determining the concentration of total troponin i in a biological sample
ATE200353T1 (de) Kompetitiver immuntest unter verwendung komplexierter analytderivate
SE0100595D0 (sv) Immunological detection of prostate diseases and prostatic-related diseases
ITMI930477A1 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
DK1210606T3 (da) Bruskresorptionsassays
FI904304A0 (fi) Foerfarande foer paovisande av analyter.
CA2239882A1 (en) Method of determining or detecting donor organ damage following xenotransplantation based on donor organ-derived analytes
Messina et al. LIF based fluorescent immunosensor using AP-SNs and QDs for quantitation of IgG anti Toxocara canis in human serum samples

Legal Events

Date Code Title Description
FD Application lapsed

Free format text: ABB OY